GLP-1 drugs shouldn’t panic food & drink just yet

ozempic aom obesity medicine health diabetes GettyImages-1393991963

The introduction of next gen weight loss drugs is attracting huge attention from brands and consumers alike, says Toby Clark, vice president of Mintel Consulting, EMEA

“Don’t panic.” The iconic advice from The Hitchhiker’s Guide to the Galaxy for intergalactic travellers also applies to any UK food and drink brands concerned about the potential impact of weight-loss drugs on the industry.

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW